BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16204161)

  • 1. The cost-effectiveness of screening the U.S. blood supply for West Nile virus.
    Custer B; Busch MP; Marfin AA; Petersen LR
    Ann Intern Med; 2005 Oct; 143(7):486-92. PubMed ID: 16204161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summaries for patients. The cost-effectiveness of screening the U.S. blood supply for West Nile virus.
    Ann Intern Med; 2005 Oct; 143(7):I44. PubMed ID: 16204157
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.
    Busch MP; Caglioti S; Robertson EF; McAuley JD; Tobler LH; Kamel H; Linnen JM; Shyamala V; Tomasulo P; Kleinman SH
    N Engl J Med; 2005 Aug; 353(5):460-7. PubMed ID: 16079369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-associated transmission of West Nile virus--Arizona, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Sep; 53(36):842-4. PubMed ID: 15371966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. West Nile virus among blood donors in the United States, 2003 and 2004.
    Stramer SL; Fang CT; Foster GA; Wagner AG; Brodsky JP; Dodd RY
    N Engl J Med; 2005 Aug; 353(5):451-9. PubMed ID: 16079368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of West Nile virus through blood transfusion in the United States in 2002.
    Pealer LN; Marfin AA; Petersen LR; Lanciotti RS; Page PL; Stramer SL; Stobierski MG; Signs K; Newman B; Kapoor H; Goodman JL; Chamberland ME;
    N Engl J Med; 2003 Sep; 349(13):1236-45. PubMed ID: 14500806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening the Blood Supply for Zika Virus in the 50 U.S. States and Puerto Rico: A Cost-Effectiveness Analysis.
    Russell WA; Stramer SL; Busch MP; Custer B
    Ann Intern Med; 2019 Feb; 170(3):164-174. PubMed ID: 30615781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of alternative blood-screening strategies for West Nile Virus in the United States.
    Korves CT; Goldie SJ; Murray MB
    PLoS Med; 2006 Feb; 3(2):e21. PubMed ID: 16381598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making.
    Custer B; Tomasulo PA; Murphy EL; Caglioti S; Harpool D; McEvoy P; Busch MP
    Transfusion; 2004 Nov; 44(11):1547-54. PubMed ID: 15504158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meeting transfusion safety expectations.
    AuBuchon JP
    Ann Intern Med; 2005 Oct; 143(7):537-8. PubMed ID: 16204166
    [No Abstract]   [Full Text] [Related]  

  • 11. Reacting to an emerging safety threat: West Nile virus in North America.
    Stramer SL
    Dev Biol (Basel); 2007; 127():43-58. PubMed ID: 17486880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: West Nile virus screening of blood donations and transfusion-associated transmission--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(13):281-4. PubMed ID: 15071426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.
    Paltiel AD; Walensky RP; Schackman BR; Seage GR; Mercincavage LM; Weinstein MC; Freedberg KA
    Ann Intern Med; 2006 Dec; 145(11):797-806. PubMed ID: 17146064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keeping Blood Transfusion Safe From West Nile Virus: American Red Cross Experience, 2003 to 2012.
    Dodd RY; Foster GA; Stramer SL
    Transfus Med Rev; 2015 Jul; 29(3):153-61. PubMed ID: 25841631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-associated transmission of West Nile virus, United States 2003 through 2005.
    Montgomery SP; Brown JA; Kuehnert M; Smith TL; Crall N; Lanciotti RS; Macedo de Oliveira A; Boo T; Marfin AA;
    Transfusion; 2006 Dec; 46(12):2038-46. PubMed ID: 17176314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2003 West Nile virus United States epidemic: the America's Blood Centers experience.
    Kleinman S; Glynn SA; Busch M; Todd D; Powell L; Pietrelli L; Nemo G; Schreiber G; Bianco C; Katz L;
    Transfusion; 2005 Apr; 45(4):469-79. PubMed ID: 15819665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. West Nile virus transmission through blood transfusion--South Dakota, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Feb; 56(4):76-9. PubMed ID: 17268405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From the Centers for Disease Control and Prevention. Investigations of West Nile virus infections in recipients of blood transfusions.
    JAMA; 2002 Nov; 288(20):2535-6. PubMed ID: 12465622
    [No Abstract]   [Full Text] [Related]  

  • 19. As West Nile virus season heats up, blood safety testing lags behind.
    Mitka M
    JAMA; 2003 May; 289(18):2341-2. PubMed ID: 12746340
    [No Abstract]   [Full Text] [Related]  

  • 20. Transmission of West Nile virus from an organ donor to four transplant recipients.
    Iwamoto M; Jernigan DB; Guasch A; Trepka MJ; Blackmore CG; Hellinger WC; Pham SM; Zaki S; Lanciotti RS; Lance-Parker SE; DiazGranados CA; Winquist AG; Perlino CA; Wiersma S; Hillyer KL; Goodman JL; Marfin AA; Chamberland ME; Petersen LR;
    N Engl J Med; 2003 May; 348(22):2196-203. PubMed ID: 12773646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.